XML 19 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statement of Stockholders' Equity - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Beginning balance, shares at Jun. 30, 2018 0 1,794,762      
Beginning balance, amount at Jun. 30, 2018 $ 0 $ 179 $ 92,681,918 $ (79,257,592) $ 13,424,505
Stock-based compensation, shares   2,681,422      
Stock-based compensation, amount   $ 270 1,021,931   1,022,201
Common stock issued to employee, shares   9,000      
Common stock issued to employee, amount   $ 1 11,689   11,690
Issuance of preferred, common stock and warrants, net of cash issuance costs, shares 8,342,993 1,777,007      
Issuance of preferred, common stock and warrants, net of cash issuance costs, amount $ 834 $ 178 11,810,373   11,811,385
Warrants issued in connection with the registered offering     1,827,628   1,827,628
Warrants issued in connection with the registered offering to the placement agents, non-cash issuance costs     61,024   61,024
Preferred converted into common stock, shares (7,899,160) 7,899,160      
Preferred converted into common stock, amount $ (790) $ 789 1   0
Issued preferred stock, shares 400,000        
Issued preferred stock, amount $ 40   519,560   519,600
Issuance of preferred, common stock related to debt conversion, shares 2,751,148 3,120,064      
Issuance of preferred, common stock related to debt conversion, amount $ 275 $ 312 4,666,897   4,667,484
Warrants issued in connection with debt conversion     499,183   499,183
Warrant and option exercises, shares   250,007      
Warrant and option exercises, amount   $ 25 375,001   375,026
Rounding from reverse stock split   6,649      
Net loss (27,131,908) (27,131,908)
Ending balance, shares at Jun. 30, 2019 3,594,981 17,538,071      
Ending balance, amount at Jun. 30, 2019 $ 359 $ 1,754 113,475,205 (106,389,500) 7,087,818
Stock-based compensation, shares   1,952,912      
Stock-based compensation, amount   $ 196 1,079,115   1,079,311
Issuance of Series H preferred stock and common stock due to acquisition of Innovus, shares 1,997,902 3,809,712      
Issuance of Series H preferred stock and common stock due to acquisition of Innovus, amount $ 200 $ 381 4,405,603   4,406,184
Issuance of Series F preferred stock from October 2019 private placement financing, net of issuance costs, shares 10,000        
Issuance of Series F preferred stock from October 2019 private placement financing, net of issuance costs, amount $ 1   5,249,483   5,249,484
Issuance of preferred, common stock and warrants, net of cash issuance costs, shares   36,365,274      
Issuance of preferred, common stock and warrants, net of cash issuance costs, amount   $ 3,637 33,275,119   33,278,756
Warrants issued in connection with the registered offering     9,723,161   9,723,161
Warrants issued in connection with the registered offering to the placement agents, non-cash issuance costs     1,458,973   1,458,973
Issuance of common stock, net of issuance costs, shares   4,302,271      
Issuance of common stock, net of issuance costs, amount   $ 430 4,982,009   49,982,439
Preferred converted into common stock, shares (15,408,728) 25,398,728      
Preferred converted into common stock, amount $ (1,541) $ 2,540 91,881   92,880
Issuance of Series G preferred stock due to acquisition of Cerecor, shares 9,805,845        
Issuance of Series G preferred stock due to acquisition of Cerecor, amount $ 981   5,558,933   5,559,914
Issuance of preferred, common stock related to debt conversion, shares   1,842,046      
Issuance of preferred, common stock related to debt conversion, amount   $ 185 2,578,679   2,578,864
Cashless warrant exercise, shares   12,915,770      
Cashless warrant exercise, amount   $ 1,292 (1,292)   0
Warrant and option exercises, shares   20,186,994      
Warrant and option exercises, amount   $ 2,018 26,989,823   26,991,841
Common stock issued to consultants, shares   165,000      
Common stock issued to consultants, amount   $ 16 230,984   231,000
Issuance of common stock related to settlement, shares   122,375      
Issuance of common stock related to settlement, amount   $ 12 173,602   173,614
CVR payouts, shares   1,238,204      
CVR payouts, amount   $ 123 1,732,747   1,732,870
Net loss (13,620,679) (13,620,679)
Ending balance, shares at Jun. 30, 2020 0 125,837,357      
Ending balance, amount at Jun. 30, 2020 $ 0 $ 12,584 $ 215,012,891 $ (120,010,179) $ 95,015,296